NYX-2925 - CAS 2012536-16-0

NYX-2925, an orally active NMDAR (N-methyl-D-aspartate receptor) modulator, enhances activated Src levels and Src phosphorylation at GluN2A and GluN2B sites in the mPFC (medial prefrontal cortex), without affecting CAMKII (Ca2+/calmodulin-dependent protein kinase II) or exhibiting addictive or sedative/ataxic side effects. It is utilized in the study of various CNS (central nervous system) disorders mediated by NMDA receptors.

Others, iGluR

Neuroscience, Others, Membrane transporter/Ion channel

2012520

C14H23N3O4

297.35

C(C(C)C)(=O)N1[C@]2(C(=O)N([C@@H]([C@@H](C)O)C(N)=O)C2)CCC1

-20°C

Ice Packs

Small Compound